Mary K. Danks

Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

Peter J. Houghton, Pamela J. Cheshire, James D. Hallman et al. · Cancer Chemotherapy and Pharmacology · 1995 · 406 citations

Human Tumors, Oncology, Medicine +9

Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26).

Mary K. Danks, Jack C. Yalowich, William T. Beck · PubMed · 1987 · 227 citations

Molecular Pharmacology, Drug Resistance Analysis, Vinca Alkaloids +13

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26

Mary K. Danks, Carla Schmidt, Margaret C. Cirtain et al. · Biochemistry · 1988 · 221 citations

Identification and Characterization of Novel Benzil (Diphenylethane-1,2-dione) Analogues as Inhibitors of Mammalian Carboxylesterases

Randy M. Wadkins, Janice L. Hyatt, Xin Wei et al. · Journal of Medicinal Chemistry · 2005 · 183 citations · Full text

Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.

William T. Beck, Margaret C. Cirtain, Mary K. Danks et al. · PubMed · 1987 · 182 citations

Mdr Gene, Chemoprevention Strategy, Immunology +21